The Nuestros Días ("Our Days") Study

NCT06475534 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-06-29

No results posted yet for this study

Summary

The goal of this observational study is to understand how contextual, individual-level, and cultural factors influence the daily and long-term well-being of caregivers of relatives with memory problems or dementia. The study focuses on caregivers from the Hispanic and Latino community. The main questions it aims to answer are:

* What daily factors increase (i.e., risk factors) or decrease (i.e., protective factors) the daily odds of depression and anxiety symptoms reported by caregivers?
* How do these symptoms vary over time?
* Do variations in depression and anxiety symptoms predict distal health outcomes?

Participants will:

* Complete an online baseline survey to understand their caregiving situation.
* Fill out daily surveys online for three weeks about their caregiving experiences and well-being.
* Complete two follow-up surveys, along with daily surveys, six and twelve months after the baseline survey.

All the study information and surveys can be completed in English or Spanish based on the participant's preference.

Conditions

  • Caregiver Burden
  • Well-Being, Psychological
  • Stress, Psychological
  • Depression
  • Anxiety

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH
  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Frank Puga, PhD · Univeristy of Alabama at Birmingham

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-27
Primary Completion
2027-03-31
Completion
2027-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06475534 on ClinicalTrials.gov